Misha Blagosklonny’s Bold Theory of Aging Continues to Reshape Biogerontology

A new essay in the journal Aging revisits the scientific legacy of Mikhail “Misha” Blagosklonny, the physician-scientist whose unconventional ideas helped transform debates about why organisms grow old. Published in Volume 18 of Aging on August 6, 2026, the article, titled “Misha Blagosklonny: a life of ideas,” examines the theories, research strategy, and intellectual influence of a scientist who argued that aging may be driven less by passive molecular deterioration than by biological programs that remain active long after their useful period has ended.

Written by David Gems of University College London and Marco Demaria of the European Research Institute for the Biology of Ageing at the University Medical Center Groningen, the essay is not a report of new laboratory experiments. Instead, it analyzes Blagosklonny’s scientific contributions and explains why his conceptual approach continues to attract attention across aging biology, cancer research, evolutionary physiology, and medicine. The authors portray him as a highly original thinker who used existing experimental evidence to construct new mechanistic explanations for age-related decline.

Blagosklonny began his career as a physician and experimental scientist before establishing an influential research program in oncology and gerontology in the United States. His work connected cancer biology with the biology of aging, particularly through the mechanistic target of rapamycin, or mTOR, a central nutrient-sensing pathway. mTOR regulates protein synthesis, cell growth, metabolism, and proliferation. It is essential during development and reproductive maturity, but persistent activation later in life can promote pathological growth, cellular stress, and senescence, a state in which cells remain metabolically active but permanently stop dividing.

This observation became a foundation of Blagosklonny’s hyperfunction theory of aging. According to the theory, many age-related disorders arise because biological processes that are beneficial early in life continue operating after growth and development are complete. The result is not simply a body wearing down from accumulated damage, but a system in which normal growth-promoting activity becomes excessive and harmful. In this framework, aging is linked to the overactivity of pathways involved in development, metabolism, tissue growth, and reproduction.

A key concept in Blagosklonny’s model is the “quasi-program.” He rejected the idea that evolution directly programmed organisms to deteriorate and die at a predetermined age. Instead, he proposed that aging represents the unintended continuation of genetically regulated developmental programs. These programs are not “designed” to cause aging; they become damaging because evolution favored their early-life benefits without fully eliminating their late-life consequences. The theory therefore combines molecular mechanisms with evolutionary principles such as antagonistic pleiotropy, in which the same biological trait can improve fitness early in life while producing harmful effects later.

The hyperfunction theory challenges the traditional disposable soma model, which attributes aging primarily to limited investment in cellular maintenance and the gradual accumulation of molecular damage. The disposable soma framework emphasizes imperfect DNA repair, protein quality control, antioxidant defenses, and other forms of somatic preservation. Blagosklonny’s alternative does not deny that damage accumulates, but it places greater emphasis on the active biological signals that can accelerate dysfunction. In particular, excessive signaling through mTOR, growth hormone, and insulin-like growth factor 1, or IGF-1, may drive tissue changes that become increasingly pathological with age.

This reasoning also offers a mechanistic interpretation of several lifespan-extending interventions. Rapamycin, a drug that inhibits mTOR, has attracted major interest because experiments in laboratory animals have shown that it can extend lifespan and delay multiple age-related diseases. Caloric restriction, which reduces nutrient availability and alters insulin and IGF-1 signaling, has likewise been associated with longevity benefits in several organisms. From Blagosklonny’s perspective, these interventions may work not merely by slowing the accumulation of damage, but by reducing persistent growth signals that continue to push aging tissues toward dysfunction.

The authors emphasize that Blagosklonny’s influence extended beyond any single hypothesis. Through an exceptionally large body of theoretical writing and his editorial leadership, he encouraged researchers to connect findings that are often studied in isolation. His work prompted scientists to consider how cancer, cellular senescence, metabolism, development, and aging might be linked through shared signaling networks. The essay suggests that this integrative style of reasoning has helped stimulate continuing research into programmatic theories of aging, biological clocks, reproductive decline, and the late-life emergence of chronic disease.

Whether the hyperfunction theory becomes a universally accepted explanation of aging remains unresolved. Aging is biologically complex, and evidence supports contributions from genomic instability, mitochondrial dysfunction, inflammation, impaired protein homeostasis, stem-cell exhaustion, and altered intercellular communication, among other processes. Nevertheless, the theory has remained influential because it offers a testable explanation for why pathways that are indispensable in youth can become damaging in later life, and why interventions that restrain growth signaling may influence lifespan. The new essay concludes that, regardless of which elements ultimately enter the mainstream, Blagosklonny’s ideas have permanently shaped scientific discussion. His legacy lies not only in specific claims about aging, but also in his insistence that conceptual research—when grounded in evidence—can reveal connections that conventional experiments may overlook.

Subject of Research: Aging biology, biogerontology, hyperfunction theory, evolutionary physiology, and programmatic theories of aging

Article Title: Misha Blagosklonny: a life of ideas

News Publication Date: August 10, 2026

Web References: https://doi.org/10.18632/aging.206412; Aging, Volume 18; Mikhail Blagosklonny profile

References: Gems D, Demaria M. “Misha Blagosklonny: a life of ideas.” Aging. DOI: 10.18632/aging.206412.

Image Credits: Copyright © 2026 Gems and Demaria. Open access under the Creative Commons Attribution License (CC BY 4.0).

Keywords: aging, hyperfunction theory, mTOR, rapamycin, caloric restriction, cellular senescence, quasi-program, disposable soma, biogerontology, evolutionary physiology, Mikhail Blagosklonny